- Net sales grew 2% (cc[1], +2% USD), with growth in all divisions:
- Cosentyx (USD 556 million, +83% cc) showed strong growth across all indications
- Entresto (USD 128 million, +138% cc) grew driven by improved access and US sales force expansion
- Excluding Gleevec/Glivec, Oncology grew 11% (cc)
- Alcon was up 7%[2] (cc) with strong growth in Surgical and continued growth in Vision Care
- Sandoz grew 1% (cc) driven by growth outside the US, fully offsetting US price pressure
…
- Net sales grew 2% (cc[1], +2% USD), with growth in all divisions:
- Cosentyx (USD 556 million, +83% cc) showed strong growth across all indications
- Entresto (USD 128 million, +138% cc) grew driven by improved access and US sales force expansion
- Excluding Gleevec/Glivec, Oncology grew 11% (cc)
- Alcon was up 7%[2] (cc) with strong growth in Surgical and continued growth in Vision Care
- Sandoz grew 1% (cc) driven by growth outside the US, fully offsetting US price pressure
…
Follow us on Facebook
ADDRESS – ZIMBABWE
Suite 204, Block 1
Long Cheng Plaza
Mutley Bend, Belvedere
Harare, Zimbabwe
ADDRESS – ZAMBIA
Plot 43504
Apex Chalala
Off Kasama Road
Lusaka Zambia